PsiThera raises $47.5 million Series A, names new CEO
bolt Executive Summary
- PsiThera closed a $47.5 million Series A round. Samsara Biocapital and Lightstone Ventures led. Eric Shaff joins as new CEO.
- View source
PsiThera closed a $47.5 million Series A round. Samsara Biocapital and Lightstone Ventures led. Eric Shaff joins as new CEO.
Funding details: $47.5 million (Series A)
Full Story
PsiThera raised $47.5 million in Series A financing. Samsara Biocapital and Lightstone Ventures led the equity round. Other investors include Roivant, YK Bioventures, Eurofarma Ventures, and more. The company came from a Roivant spinout and now runs independently.
Eric Shaff started as CEO. He brings experience from Seres Therapeutics. The leadership also has Woody Sherman as Founder and Chief Innovation Officer, and Camil Sayegh as Chief Scientific Officer.
The funding advances a pipeline of oral drugs for immune and inflammatory diseases. It starts with TNF superfamily programs. The company uses its QUAISAR platform with molecular dynamics and AI to model proteins and drugs.
Investors like the setup. Christina Isacson from Lightstone Ventures, now board chair, said it mixes computation and science well for tough targets. Eric Shaff said the platform sped their lead program from hit to optimization in four months. Woody Sherman said it beats limits of old methods on moving molecules.
PsiThera makes oral drugs for immune and inflammatory diseases. It uses biophysics, AI modeling, and biology to hit targets once limited to injectables. The pipeline targets TNF superfamily members for patients with those conditions.
The announcement is on the PsiThera press release.
Filed Under
Recommended next
View all
OpenAI acquires health-tech startup Torch for over USD 100 million
OpenAI has acquired US-based health-tech startup Torch. The deal is valued at more than USD 100 million and strengthens OpenAI’s push into healthcare.
Paws Raises INR 29.3 Crore Pre-Series A Led by Chiratae Ventures
Bengaluru-based Dr. Paws raised INR 29.3 crore in pre-Series A funding. Chiratae Ventures led the round with Sauce joining. Trifecta Capital and Stride Ventures provided venture debt.
Earthful Raises INR 26 Crore Pre-Series A Funding
Hyderabad-based Earthful raised INR 26 crore in pre-Series A funding. Fireside Ventures and V3 Ventures led the round. Atrium Angels joined in.
EpilepsyGTx raises $33 million Series A for epilepsy gene therapy
EpilepsyGTx raised $33 million in Series A funding. XGEN Venture, British Business Bank invested. Funds advance EPY201 through Phase I/IIa trials.
Stay ahead of the curve
Get the latest business and tech insights delivered to your inbox daily.